Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
105.10
(
0.00%
)
Bitcoin
68,786.47
(
-0.15%
)
News Focus
News Focus
Post# of 257268
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

puravida

Send PM Follow Ignore
Followers 36
Posts 1737
Boards Moderated 0
Alias Born 05/13/2011

puravida

Re: None

Monday, 05/04/2020 8:51:09 AM

Monday, May 04, 2020 8:51:09 AM

Post# of 257268

Acquisition of Stemline establishes Menarini’s presence in the U.S. biopharmaceutical oncology market
Menarini will support further development of Stemline’s ELZONRIS® and enable global expansion by leveraging its commercial infrastructure in Europe and other ex-U.S. geographies

Total potential consideration of $12.50 per share comprising $11.50 cash and $1.00Contingent Value Right (CVR)


https://ir.stemline.com/news-releases/news-release-details/menarini-group-acquire-stemline-therapeutics-transaction-valued
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today